2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureTheresa A. McDonagh, Robert J. Mentz, Claudio Muneretto et al.|European Heart Journal|2023Cited by 2.2k
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trialIacopo Olivotto, Amos Katz, Artur Oręziak et al.|The Lancet|2020Cited by 1.2k
Cardiopoietic Stem Cell Therapy in Heart FailureJozef Bartúnek, André Terzic, Atta Behfar et al.|Journal of the American College of Cardiology|2013Cited by 485
Unbiased plasma proteomics for novel diagnostic biomarkers in cardiovascular disease: identification of quiescin Q6 as a candidate biomarker of acutely decompensated heart failureAlexandre Mebazaa, Koen Kas, Griet Vanpoucke et al.|European Heart Journal|2012Cited by 82
Pathophysiology, Diagnosis, and Treatment of Patients with Concomitant Severe Aortic Stenosis and Coronary Artery Disease: A Closer Look to the Unresolved PerplexityGiuseppe Di Gioia, Marko Banović, Jozef Bartúnek et al.|Journal of Clinical Medicine|2021Cited by 69